AD6, a coumarin derivative, and other pharmacological approaches to splanchnic artery occlusion (SAO) shock therapy.
Squadrito
F
F
Institutes of Pharmacology, Medical School, University of Messina, Italy.
Sturniolo
R
R
Altavilla
D
D
Caputi
A P
AP
D000818:Animals; D002866:Chromonar / Q000031:analogs & derivatives* / Q000494:pharmacology; D003295:Convulsive Therapy / Q000379:methods*; D004195:Disease Models, Animal; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000502:physiology; D008297:Male; D009553:Nimodipine / Q000494:pharmacology; D010587:Phagocytosis / Q000187:drug effects / Q000502:physiology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013152:Splanchnic Circulation / Q000187:drug effects*
D010975:Platelet Aggregation Inhibitors; D009553:Nimodipine; C025945:cloricromen; D002866:Chromonar